China Sxt Pharmaceuticals Inc (SXTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 09-2025 | 03-2025 | 09-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,176 | 21,198 | 18,129 | 18,513 | 12,077 |
| Receivables | 3,005 | 2,701 | 1,719 | 1,664 | 1,315 |
| Inventories | 777 | 751 | 828 | 867 | 795 |
| Other current assets | 2,552 | 1,088 | 620 | 944 | 46 |
| TOTAL | $34,510 | $26,042 | $21,296 | $21,988 | $14,233 |
| Non-Current Assets | |||||
| PPE Net | 2,738 | 153 | 2,603 | 2,736 | 2,751 |
| Investments And Advances | 0 | 0 | 0 | 8,550 | 8,310 |
| Intangibles | 0 | 9 | 0 | 0 | 0 |
| Other Non-Current Assets | 6 | 149 | 12 | 16 | 19 |
| TOTAL | $2,744 | $311 | $2,615 | $11,302 | $11,080 |
| Total Assets | $34,755 | $26,353 | $21,664 | $30,997 | $23,127 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 355 | 981 | 711 | 2,097 | 2,294 |
| Accounts payable and accrued liabilities | 498 | 531 | 1,158 | 1,663 | 1,280 |
| Accrued Expenses | 3,305 | 3,267 | 2,938 | 2,923 | 2,768 |
| Other current liabilities | 121 | 81 | 113 | 7,857 | 1,449 |
| TOTAL | $4,349 | $5,962 | $6,012 | $15,664 | $8,902 |
| Non-Current Liabilities | |||||
| Long Term Debt | 644 | 73 | 96 | 115 | 117 |
| Other Non-Current Liabilities | 0 | 85 | 0 | 0 | 0 |
| TOTAL | $644 | $158 | $96 | $115 | $117 |
| Total Liabilities | $5,047 | $6,120 | $6,224 | $15,962 | $9,197 |
| Shareholders' Equity | |||||
| Common Shares | 64,126 | 55,385 | 44,531 | 7,729 | 4,352 |
| Retained earnings | -34,220 | -34,384 | -28,015 | -25,514 | -24,712 |
| Other shareholders' equity | -199 | -767 | -1,076 | -569 | -1,026 |
| TOTAL | $29,707 | $20,234 | $15,440 | $15,035 | $13,930 |
| Total Liabilities And Equity | $34,754 | $26,353 | $21,664 | $30,997 | $23,127 |